InnoCan Pharma (InnoCan Pharma) FCF Yield % : -6.66 (As of May. 15, 2024)

View and export this data going back to 2020. Start your Free Trial

What is InnoCan Pharma FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, InnoCan Pharma's Trailing 12-Month Free Cash Flow is $-3.95 Mil, and Market Cap is $58.53 Mil. Therefore, InnoCan Pharma's FCF Yield % for today is -6.66%.

The historical rank and industry rank for InnoCan Pharma's FCF Yield % or its related term are showing as below:

INNPF' s FCF Yield % Range Over the Past 10 Years
Min: -16.99 Med: -7.47 Max: -5.19
Current: -6.66

During the past 6 years, the highest FCF Yield % of InnoCan Pharma was -5.19%. The lowest was -16.99%. And the median was -7.47%.

INNPF's FCF Yield % is ranked worse than
70.24% of 1082 companies
in the Drug Manufacturers industry
Industry Median: -0.52 vs INNPF: -6.66

InnoCan Pharma's FCF Margin % for the quarter that ended in Dec. 2023 was -26.98%.

InnoCan Pharma FCF Yield % Historical Data

The historical data trend for InnoCan Pharma's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InnoCan Pharma FCF Yield % Chart

InnoCan Pharma Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

-7.93

-4.20

-11.35

-4.91

InnoCan Pharma Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Yield %	Get a 7-Day Free Trial															-10.24	-9.98	-5.91	-4.91	-6.57

Competitive Comparison of InnoCan Pharma's FCF Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, InnoCan Pharma's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

InnoCan Pharma's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, InnoCan Pharma's FCF Yield % distribution charts can be found below:

* The bar in red indicates where InnoCan Pharma's FCF Yield % falls into.

InnoCan Pharma FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

InnoCan Pharma's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-3.95	/	80.4006
	=	-4.91%

InnoCan Pharma's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-1.32	*	4	/	80.4006
	=	-6.57%

InnoCan Pharma FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

InnoCan Pharma FCF Yield % Related Terms

Thank you for viewing the detailed overview of InnoCan Pharma's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

InnoCan Pharma (InnoCan Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » InnoCan Pharma Corp (OTCPK:INNPF) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

IP4:Germany INNO:Canada

Address

1015, 926 - 5 Avenue SW, Calgary, AB, CAN, T2P 0N7

Website

https://www.innocanpharma.com

InnoCan Pharma Corp is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining cannabidiol with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals. Geographically, it derives a majority of its revenue from the United States.